Carrier-free biologically-active protein nanostructures
US10226510B2 - Carrier-free biologically-active protein nanostructures - Google Patents
US10226510B2 - Carrier-free biologically-active protein nanostructures - Google Patents …
US10226510B2 - Carrier-free biologically-active protein nanostructures - Google Patents …
Carrier-free biologically-active protein nanostructures
The present disclosure provides compositions and methods for efficient and effective protein
delivery in vitro and in vivo. In some aspects, proteins are reversibly crosslinked to each …
delivery in vitro and in vivo. In some aspects, proteins are reversibly crosslinked to each …
Carrier-free biologically-active protein nanostructures
5,464,629 A 5,753,261 A 5,773,006 A 6,117,982 A 6,120,751 A 6,194,388 B1 6,197,298 B1
6,319,715 B1 6,544,549 B1 6,693,086 B1 6,787,132 B1 7,108,863 B2 7,122,202 B2 …
6,319,715 B1 6,544,549 B1 6,693,086 B1 6,787,132 B1 7,108,863 B2 7,122,202 B2 …
Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2022 - Google Patents
The present specification discloses a pharmaceutical composition comprising an active
agent that causes reduction of the level of systemic immunosuppression in an individual for …
agent that causes reduction of the level of systemic immunosuppression in an individual for …
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2021 - Google Patents
(57) ABSTRACT A pharmaceutical composition comprising an active agent that causes
reduction of the level of systemic immunosuppression in an individual for use in treating a …
reduction of the level of systemic immunosuppression in an individual for use in treating a …
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2021 - Google Patents
US10981989B2 - Reducing systemic regulatory T cell levels or activity for treatment of disease
and injury of the CNS - Google Patents US10981989B2 - Reducing systemic regulatory T cell …
and injury of the CNS - Google Patents US10981989B2 - Reducing systemic regulatory T cell …
Carrier-free biologically-active protein nanostructures
The present disclosure provides compositions and methods for efficient and effective protein
delivery in vitro and in vivo. In some aspects, proteins are reversibly crosslinked to each …
delivery in vitro and in vivo. In some aspects, proteins are reversibly crosslinked to each …
Cell surface coupling of nanoparticles
US11261226B2 - Cell surface coupling of nanoparticles - Google Patents US11261226B2 -
Cell surface coupling of nanoparticles - Google Patents Cell surface coupling of nanoparticles …
Cell surface coupling of nanoparticles - Google Patents Cell surface coupling of nanoparticles …
Methods of conditioning patients for T cell therapy
A Bot, JS Wiezorek, GO William, J Rajul… - US Patent …, 2019 - Google Patents
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in
need thereof. The invention includes a method of conditioning a patient prior to a T cell …
need thereof. The invention includes a method of conditioning a patient prior to a T cell …
Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder
M Eisenbach-Schwartz, K Baruch… - US Patent …, 2023 - Google Patents
2020-02-17 Assigned to YEDA RESEARCH AND DEVELOPMENT CO., LTD. reassignment
YEDA RESEARCH AND DEVELOPMENT CO., LTD. ASSIGNMENT OF ASSIGNORS …
YEDA RESEARCH AND DEVELOPMENT CO., LTD. ASSIGNMENT OF ASSIGNORS …